Ledger.Open graph →
SEC Form D · filed May 20, 2024

Alphyn Biologics, Inc

Offering
$1.8M
Sold
$1.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
ANNAPOLIS, MD
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Gary Pekoe · Annapolis, MDExec · DirectorAdel Mikhail · Annapolis, MDDirectorSteven Pentelnik · Annapolis, MDExecNeal Koller · Annapolis, MDExec · DirectorRoger Griggs · Annapolis, MDDirectorJeffrey Kossak · Annapolis, MDDirectorRoger Griggs · Annapolis, MDDirectorSteven Pentelnik · Annapolis, MDExecNeal Koller · Annapolis, MDExec · DirectorGary Pekoe · Annapolis, MDExec · DirectorJeffrey Kossak · Annapolis, MDDirectorAdel Mikhail · Annapolis, MDDirectorShannon Kaustinen · Vancouver, British Columbia, CanadaExecAngela Doll · Vancouver, British Columbia, CanadaDirectorDavid Van Seters · Vancouver, British Columbia, CanadaExec · DirectorDalco GP I, LLC · Irvine, CADirectorScott Dragoo · NEW YORK, NYDirectorDavid Lin · NEW YORK, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗